Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
Glycated Albumin Market aims to provide a comprehensive presentation of the global market for Glycated Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Albumin. Glycated Albumin Market contains market size and forecasts of Glycated Albumin in global, including the following market information:
- Global Glycated Albumin Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Glycated Albumin Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Glycated Albumin companies in 2022 (%)
The global Glycated Albumin market was valued at US$ 441.4 million in 2022 and is projected to reach US$ 608.4 million by 2029, at a CAGR of 4.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.
We surveyed the Glycated Albumin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glycated Albumin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Glycated Albumin Market Segment Percentages, by Type, 2022 (%)
- Glycated Albumin (Human)
- Glycated Albumin (Animal)
Global Glycated Albumin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Glycated Albumin Market Segment Percentages, by Application, 2022 (%)
- Hospitals and Clinics
- Laboratories
Global Glycated Albumin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Glycated Albumin Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Glycated Albumin revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Glycated Albumin revenues share in global market, 2022 (%)
- Key companies Glycated Albumin sales in global market, 2018-2023 (Estimated), (K MT)
- Key companies Glycated Albumin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Asahi Kasei Pharma
- DIAZYME
- Abnova
- LifeSpan
- Exocell
- BSBE
- Medicalsystem
- Maccura
- Leadman
- Simes Sikma
- NINGBO PUREBIO
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Glycated Albumin, market overview.
- Chapter 2: Global Glycated Albumin market size in revenue and volume.
- Chapter 3: Detailed analysis of Glycated Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Glycated Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Glycated Albumin capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.